[[Stanford University]] (M.S.)
[[Cornell University]] (Ph.D.)"},"workplaces":{"wt":"[[NCI-Frederick]]
[[National Institute of Allergy and Infectious Diseases]]
[[Office of AIDS Research]]"},"death_place":{"wt":"[[Aruba]]"},"children":{"wt":"2"},"image":{"wt":"Bonnie Mathieson.jpg"}},"i":0}}]}" id="mwCQ">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}
Bonnie Mathieson | |
---|---|
![]() | |
Born | May 10, 1945 Illinois, U.S. |
Died | January 8, 2018 72) | (aged
Alma mater | University of Illinois (B.S.) Stanford University (M.S.) Cornell University (Ph.D.) |
Children | 2 |
Scientific career | |
Institutions | NCI-Frederick National Institute of Allergy and Infectious Diseases Office of AIDS Research |
Thesis | Selective expression of surface components on differentiated cells of the mouse (1976) |
Bonnie Jean Mathieson (May 10, 1945 – January 8, 2018) was an American biomedical scientist and pioneer in HIV vaccine research. Mathieson worked at the National Institutes of Health (NIH) for 43 years. She played a fundamental role in NIH HIV/AIDS research, vaccine programs, and scientific policy.
Mathieson was born May 10, 1945. She was the oldest of seven siblings. They were raised on a farm in Illinois. [1] She completed a Bachelor of Science in botany from University of Illinois in 1967. She researched retrovirology, immunology, and genetics at Stanford University where she completed a master's degree in medical microbiology. [2] [3] In 1975, Mathieson earned a doctor philosophy in biology from the Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine of Cornell University in New York City. [2] Her dissertation was titled Selective expression of surface components on differentiated cells of the mouse: immunoselection of Y-bearing sperm in an in vitro fertilization system and expression of the thymocyte surface markers G(IX), TL and LY in tetraparental mice. [4] She was a post-doctoral researcher and staff fellow at National Institute of Allergy and Infectious Diseases (NIAID) where she researched lymphocyte surface markers and T cell subsets from 1975 to 1982. [2]
Mathieson researched T and B lymphocytes at Basel Institute for Immunology as a member from 1982 to 1983. From 1983 to 1989, she studied NK cells and T cell subsets as the head of a laboratory in the Biological Response Modifiers Program at the NCI-Frederick. Mathieson served as a program officer in the Vaccine Branch in the Division of AIDS in NIAID from 1989 to 1995. As a program officer, she developed funding opportunity announcements for HIV vaccine, immunology, and pediatric AIDS research. Mathieson is a past chair of the HIV/AIDS Vaccine Coordinating Committee in the Office of AIDS Research (OAR). She was on the WHO-UNAIDS Vaccine Advisory Committee for seven years. [2] Mathieson also served on review boards for the World Health Organization, European Commission, Canada and the Gates Foundation. She published more than 125 articles and chapters. She served as a health scientist administrator in OAR. She was the lead for HIV/AIDS vaccines at OAR and advanced the NIH AIDS vaccine program through supporting vaccine trials and developing a vaccine scholars program designed to train young scientists. [3] Mathieson was an advocate for young people, women, and early-career investigators. [3] [5] Her colleagues knew her as an international leader in the HIV vaccine field and a supporter of research to prevent HIV and improve the health and outcomes of people living with HIV. Mathieson retired from the National Institutes of Health on December 29, 2017. She had a 43 year long career at the NIH. [3]
Mathieson routinely received performance awards during her tenure at NIH. She won an Alumnus Award from Weill Cornell Medical College. [3]
Mathieson was married to Donald and had a daughter and son. She died unexpectedly on January 8, 2018, while snorkeling in Aruba when she had a massive heart attack. [3] A memorial service was held at the Woodend. [1] Mathieson was survived by her husband, children, grandchildren, and five siblings. She was preceded in death by one sister. [3]
The National Institute of Allergy and Infectious Diseases is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
This is a list of AIDS-related topics, many of which were originally taken from the public domain U.S. Department of Health Glossary of HIV/AIDS-Related Terms, 4th Edition.
The Division of Acquired Immunodeficiency Syndrome (DAIDS) is a division of the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health. It was formed in 1986 as a part of the initiative to address the national research needs created by the advent and spread of the HIV/AIDS epidemic. Specifically, the Division's mission is to increase basic knowledge of the pathogenesis, natural history, and transmission of HIV disease and to support research that promotes progress in its detection, treatment, and prevention. DAIDS accomplishes this through planning, implementing, managing, and evaluating programs in (1) fundamental basic research, (2) discovery and development of therapies for HIV infection and its complications, and (3) discovery and development of vaccines and other prevention strategies.
Robert Charles Gallo is an American biomedical researcher. He is best known for his role in establishing the human immunodeficiency virus (HIV) as the infectious agent responsible for acquired immune deficiency syndrome (AIDS) and in the development of the HIV blood test, and he has been a major contributor to subsequent HIV research.
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious diseases.
Barton Ford Haynes is an American physician and immunologist internationally recognized for work in T-cell immunology, retrovirology and HIV vaccine development. Haynes is a Frederic M. Hanes Professor of Medicine and Immunology at Duke University Medical Center. He is the director of the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012. In addition, Haynes directs the B-cell Lineage Envelope Design Study, the Centralized Envelope Phase I Study, and the Role of IgA in HIV-1 Protection Study as part of the Collaboration for AIDS Vaccine Discovery (CAVD), which was funded by the Bill and Melinda Gates Foundation in 2006.
Zeda Fran Rosenberg is an American microbiologist and epidemiologist, active in HIV biology and prevention. She is the chief executive officer of the International Partnership for Microbicides (IPM). IPM was founded by Rosenberg in 2002 and is a nonprofit organization dedicated to developing microbicides and other innovative HIV prevention products and making them available for women in developing countries.
Charles R. Wira is a scientist who is specialized in endocrinology and mucosal immunology as it relates to the immune system at mucosal surfaces of the female reproductive tract.
In 1990, the Duke Human Vaccine Institute (DHVI), located in Durham, North Carolina, was formed to support interdisciplinary efforts across Duke University School of Medicine to develop vaccines and therapeutics for HIV and other emerging infections that threaten the health of people living in the United States and the world. Since 1990, DHVI investigators have been at the forefront in the battle against AIDS and specifically in the quest for an HIV vaccine.
Jay A. Levy, M.D. is an AIDS and cancer research physician. He is a professor of medicine with specialties in virology and immunology at the University of California, San Francisco (UCSF).
Lauren V. Wood is an American allergist, immunologist, and staff physician at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she has served as a principal investigator. She is known for conducting studies of vaccines for cancer, Human papillomavirus (HPV), Hepatitis C, and HIV especially for use with children, teens and young adults. She holds the rank of captain in the U.S. Public Health Service (PHS).
Julie E. Ledgerwood is an American allergist and immunologist, who is the chief medical officer and serves as chief of the Clinical Trials Program at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in Bethesda, Maryland. She is a Doctor of Osteopathic Medicine.
Nelson L. Michael is an American infectious disease researcher. He has served for nearly 30 years in the United States Army and been directly involved with significant advancements in understanding the pathology of and vaccine development for diseases like HIV, Zika, Ebola and more. Much of his career has been spent at the Walter Reed Army Institute of Research.
Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.
Nancy Jean Sullivan is an American cell biologist researching filovirus immunology and vaccine development. She is a senior investigator and chief of the biodefense research section at the Vaccine Research Center. Her team discovered the monoclonal antibody, mAb114.
Nicole Amy Doria-Rose (born 1970) is an American biologist. She is chief of the humoral immunology core at the Vaccine Research Center. She develops and applies assays to evaluate HIV-1 specific antibody responses during natural infection and after immunization.
Vanessa M. Hirsch is a Canadian-American veterinary pathologist and scientist. She is a senior investigator and chief of the nonhuman primate virology section at the National Institute of Allergy and Infectious Diseases. Hirsch researches AIDS pathogenesis, the evolution and origins of primate lentiviruses, and HIV vaccine development.
Silvana Romina Goldszmid is an Argentine-American biologist researching tumor immunology. She is an NIH Stadtman Investigator at the National Cancer Institute.
Mary Elizabeth Daucher is an American biologist serving as the acting chief of the vaccine production program laboratory at Vaccine Research Center of the National Institute of Allergy and Infectious Diseases.
John R. Mascola is an American physician-scientist, immunologist and infectious disease specialist. He is the director of the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also serves as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs.